SHARE PURCHASE AGREEMENT RELATING TO BIONICHE PHARMA HOLDINGS LIMITED BY AND AMONG THE SELLERS NAMED HEREIN, THE OPTIONHOLDERS NAMED HEREIN MYLAN LUXEMBOURG L3 S.C.S. AND MYLAN INC.* dated as of July 14, 2010Share Purchase Agreement • July 16th, 2010 • Mylan Inc. • Pharmaceutical preparations • Delaware
This Share Purchase Agreement (“Agreement”) is made as of July 14, 2010, by and among Mylan Luxembourg L3 S.C.S., a limited partnership under the laws of Luxembourg (the “Buyer”), solely with respect to Sections 4(e) and 5(k) hereof, Mylan Inc., a Pennsylvania corporation (“Mylan”), Bioniche Pharma Holdings Limited, a limited company incorporated in the Republic of Ireland (company registration number 412552) whose registered office is Inverin, Co. Galway (the “Company”), the persons listed as Shareholders on the signature pages hereto (collectively referred to herein as “Sellers” and individually as “Seller”) and the Optionholders (as defined herein). The Buyer, the Company, the Optionholders and the Sellers are each referred to in this Agreement as a “Party” and collectively as the “Parties.”
